We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

127 hedge funds and large institutions have $521M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 133 → 127 (-6)

13% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 39

18% less capital invested

Capital invested by funds: $633M → $521M (-$112M)

39% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 44

87% less call options, than puts

Call options by funds: $280K | Put options by funds: $2.15M

Holders
127
Holders Change
-6
Holders Change %
-4.51%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
34
Increased
27
Reduced
44
Closed
39
Calls
$280K
Puts
$2.15M
Net Calls
-$1.87M
Net Calls Change
+$531K

Top Buyers

1
Invesco
Invesco
Georgia
+$16.9M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$11.6M
3
Millennium Management
Millennium Management
New York
+$11.2M
4
MWNA
Marshall Wace North America
New York
+$9.02M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.34M

Top Sellers

1
BlackRock
BlackRock
New York
-$53.6M
2
MICM
Matthews International Capital Management
California
-$22.7M
3
State Street
State Street
Massachusetts
-$21.9M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$14.9M
5
Goldman Sachs
Goldman Sachs
New York
-$7.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Pension Plan Investment Board
26
Canada Pension Plan Investment Board
Ontario, Canada
$5.21M +$5.38M +49,000 +6,749%
NIPH
27
NN Investment Partners Holdings
Netherlands
$5.14M -$540K -4,915 -9%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$5.1M +$4.23M +38,542 +378%
AP
29
AHL Partners
United Kingdom
$4.78M +$120K +1,093 +2%
AA
30
ALPS Advisors
Colorado
$4.7M +$549K +4,995 +13%
JP Morgan Chase
31
JP Morgan Chase
New York
$4.44M +$2.93M +26,656 +169%
Russell Investments Group
32
Russell Investments Group
United Kingdom
$3.44M +$3.36M +30,582 +1,355%
PP
33
Paloma Partners
Connecticut
$3.3M +$3.46M +31,473 New
AIIMS
34
Analyst IMS Investment Management Services
Israel
$3.29M – – –
LP
35
LMR Partners
United Kingdom
$3.25M +$3.41M +31,000 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$3.24M -$318K -2,890 -9%
Squarepoint
37
Squarepoint
New York
$2.71M +$2.85M +25,898 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$2.63M +$2.76M +25,098 New
OAM
39
Oxford Asset Management
United Kingdom
$1.72M +$1.8M +16,400 New
SCP
40
Seizert Capital Partners
Michigan
$1.7M +$1.78M +16,188 New
RIA
41
RPG Investment Advisory
California
$1.69M -$72.3K -658 -4%
SEI Investments
42
SEI Investments
Pennsylvania
$1.5M +$453K +4,120 +40%
ACI
43
AMP Capital Investors
Australia
$1.39M -$307K -2,797 -17%
AQR Capital Management
44
AQR Capital Management
Connecticut
$1.37M – – –
ACA
45
Anchor Capital Advisors
Massachusetts
$1.11M -$37.2K -339 -3%
Two Sigma Investments
46
Two Sigma Investments
New York
$1.09M +$1.14M +10,372 New
CSS
47
Cubist Systematic Strategies
Connecticut
$1.09M +$1.14M +10,373 New
EF
48
Empirical Finance
Pennsylvania
$1.05M -$1.16M -10,521 -51%
CS
49
Credit Suisse
Switzerland
$1.02M -$653K -5,946 -38%
CG
50
Clinton Group
New York
$998K +$1.05M +9,535 New
1
2
3 4 5

TARO Hedge Fund Activity: Q4 2017 in Review

127 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2017, worth a combined $521M — down 18% from $633M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of TARO and 34 opened new positions — a net loss of 5 holders — while 44 trimmed existing stakes and 27 added.

The largest buyer was Invesco, adding an estimated $16.9M. The largest seller was BlackRock, cutting an estimated $53.6M.

  • 127 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2017, down from 133 in Q3 2017.
  • Funds reported $521M of Taro Pharmaceutical Industries Ltd. stock for Q4 2017, down 18% quarter-over-quarter.
  • 34 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2017 and 39 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2017 was Invesco, an estimated $16.9M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2017 was BlackRock, an estimated $53.6M sold.

Based on aggregated 13F filings for Q4 2017.